Indication
COVID-19 Recurrent
2 clinical trials
2 products
Clinical trial
Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer TreatmentStatus: Recruiting, Estimated PCD: 2026-12-08
Product
COVID-19 Booster VaccineClinical trial
Evaluating the Effectiveness of Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Post-Acute Sequelae of SARS-CoV-2 (PASC)Status: Active (not recruiting), Estimated PCD: 2023-06-15
Product
Stellate Ganglion Block